Johnson & Johnson sees revenue grow 9% in the fourth quarter, amid strength in its cancer drugs.
www.marketwatch.com
#JampJ #expects #hit #billion #revenue #year #strategy #pays
J&J expects to hit $100 billion in revenue next year after new strategy pays off
